Free Trial
NASDAQ:SCLX

Scilex (SCLX) Stock Price, News & Analysis

Scilex logo
$12.94 -3.01 (-18.87%)
Closing price 04:00 PM Eastern
Extended Trading
$13.51 +0.57 (+4.40%)
As of 04:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Scilex Stock (NASDAQ:SCLX)

Key Stats

Today's Range
$12.81
$16.26
50-Day Range
$4.55
$15.95
52-Week Range
$3.60
$57.75
Volume
380,959 shs
Average Volume
111,401 shs
Market Capitalization
$89.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$455.00
Consensus Rating
Moderate Buy

Company Overview

Scilex Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
51st Percentile Overall Score

SCLX MarketRank™: 

Scilex scored higher than 51% of companies evaluated by MarketBeat, and ranked 558th out of 935 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Scilex has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Scilex has received no research coverage in the past 90 days.

  • Read more about Scilex's stock forecast and price target.
  • Earnings Growth

    Earnings for Scilex are expected to grow in the coming year, from ($0.57) to ($0.41) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Scilex is -0.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Scilex is -0.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Scilex's valuation and earnings.
  • Percentage of Shares Shorted

    8.59% of the float of Scilex has been sold short.
  • Short Interest Ratio / Days to Cover

    Scilex has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Scilex has recently decreased by 1.55%, indicating that investor sentiment is improving.
  • Dividend Yield

    Scilex does not currently pay a dividend.

  • Dividend Growth

    Scilex does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    8.59% of the float of Scilex has been sold short.
  • Short Interest Ratio / Days to Cover

    Scilex has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Scilex has recently decreased by 1.55%, indicating that investor sentiment is improving.
  • News Sentiment

    Scilex has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.04 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Scilex this week, compared to 2 articles on an average week.
  • Search Interest

    14 people have searched for SCLX on MarketBeat in the last 30 days. This is an increase of 75% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added Scilex to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Scilex insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 7.94% of the stock of Scilex is held by insiders.

  • Percentage Held by Institutions

    69.67% of the stock of Scilex is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Scilex's insider trading history.
Receive SCLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Scilex and its competitors with MarketBeat's FREE daily newsletter.

SCLX Stock News Headlines

SCLX Scilex Holding Company - Seeking Alpha
A $674B Industry Missed the Bigger Picture
TV video streaming exploded into a $674.25B market in 2024—driven by the hours we spend lost in entertainment. But there’s a much bigger habit consuming our time, with value that’s waiting to be unlocked. Smartphone screen time. We spend over 30 hours a week glued to our phones. Mode Mobile is pioneering ways to turn those hours into real income. Their EarnPhone unlocks 19 revenue streams from everyday phone use, helping users earn over $325M so far. Deloitte crowned them North America’s fastest-growing software company in 2023 after their revenue soared 32,481% from 2019-2022. But this industry is still in its infancy, and you can invest in the company that’s at the forefront of unlocking its value.
Scilex Holding Stock Price History
See More Headlines

SCLX Stock Analysis - Frequently Asked Questions

Scilex's stock was trading at $14.9240 at the start of the year. Since then, SCLX shares have decreased by 1.4% and is now trading at $14.72.

Scilex Holding Company (NASDAQ:SCLX) posted its quarterly earnings results on Friday, January, 17th. The company reported ($6.30) earnings per share for the quarter.

Scilex shares reverse split on Tuesday, April 15th 2025.The 1-35 reverse split was announced on Friday, April 11th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Monday, April 14th 2025. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Shares of SCLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Scilex investors own include Rigetti Computing (RGTI), Pfizer (PFE), BioNTech (BNTX), Hertz Global (HTZ), BlackBerry (BB).

Company Calendar

Last Earnings
1/17/2025
Today
7/30/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SCLX
CIK
1820190
Fax
N/A
Employees
80
Year Founded
N/A

Price Target and Rating

High Price Target
$630.00
Low Price Target
$245.00
Potential Upside/Downside
+3,012.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($29.02)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$72.81 million
Net Margins
-146.93%
Pretax Margin
-146.94%
Return on Equity
N/A
Return on Assets
-82.65%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.10
Quick Ratio
0.09

Sales & Book Value

Annual Sales
$50.71 million
Price / Sales
2.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($27.68) per share
Price / Book
-0.53

Miscellaneous

Outstanding Shares
6,952,000
Free Float
6,400,000
Market Cap
$101.64 million
Optionable
Optionable
Beta
1.19
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:SCLX) was last updated on 7/30/2025 by MarketBeat.com Staff
From Our Partners